InnoPharma Inc. Completes $20 Million Term Loan Facility PISCATAWAY, NJ, Nov. 13, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced that it has closed on a $20 million term loan facility, provided by Athyrium Capital Management through its...

InnoPharma Inc. Appoints Vish Shetty as Vice President, Business Development & Alliance Management PISCATAWAY, NJ, Nov. 11, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced the appointment of Vish Shetty to the role of vice president, business development & alliance management.  Mr....

InnoPharma Inc. Announces Commercial Launch of Acamprosate Delayed-Release Tablets in the United States PISCATAWAY, NJ, Aug. 15, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced the launch of acamprosate calcium, 333 mg delayed-release tablets  (generic equivalent of Campral®). ...

InnoPharma Inc. Announces Launch of Cosyntropin Injection, 0.25mg/vial in the United States PISCATAWAY, N.J., April 8, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced the commercial launch of cosyntropin injection, 0.25mg/vial  (generic equivalent of Cortrosyn®) in...

InnoPharma Inc. Announces Launch of Generic Cidofovir Injection in the United States PISCATAWAY, NJ, March 8, 2013 (GLOBE NEWSWIRE) -- InnoPharma, Inc. today announced the launch of cidofovir injection (generic equivalent of Vistide®) in 5mL single-use vials. ...